» Articles » PMID: 2580551

Hormonal Profiles in the Follicular Phase, Luteal Phase and First Trimester of Pregnancies Arising from In-vitro Fertilization

Overview
Date 1985 Apr 1
PMID 2580551
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The hormonal profiles for oestradiol-17 beta, progesterone, prolactin and beta-human chorionic gonadotrophin (beta-hCG) are documented for the first 24 pregnancies arising from in-vitro fertilization during a collaborative project between the University of Western Australia and PIVET Laboratory. All patients had ovarian follicle stimulation with clomiphene citrate, sometimes combined with human menopausal gonadotrophin and all had oocyte recovery undertaken 36 h after injection of 5000 i.u. hCG. The follicular phase profile indicated that patients were admitted for the hCG injection when oestradiol-17 beta levels were around 1500 pmol/l per follicle with a dimension of greater than or equal to 1.6 cm on ultrasound. Luteal phase data indicated that oestradiol-17 beta and progesterone levels were two to three times higher than that expected during spontaneous conception cycles and those pregnancies which subsequently aborted had significantly lower levels in the late luteal phase. During pregnancy elevated oestradiol-17 beta and progesterone levels were maintained through the early weeks during organogenesis while the beta-hCG profile was similar to that reported for spontaneous pregnancies arising without ovarian stimulation. Six women aborted and the other 18 pregnancies have generated 22 infants.

Citing Articles

The pathophysiological role of estrogens in the initial stages of pregnancy: molecular mechanisms and clinical implications for pregnancy outcome from the periconceptional period to end of the first trimester.

Parisi F, Fenizia C, Introini A, Zavatta A, Scaccabarozzi C, Biasin M Hum Reprod Update. 2023; 29(6):699-720.

PMID: 37353909 PMC: 10628507. DOI: 10.1093/humupd/dmad016.


Pharmacokinetics of hard micronized progesterone capsules via vaginal or oral route compared with soft micronized capsules in healthy postmenopausal women: a randomized open-label clinical study.

Wang H, Liu M, Fu Q, Deng C Drug Des Devel Ther. 2019; 13:2475-2482.

PMID: 31440031 PMC: 6664151. DOI: 10.2147/DDDT.S204624.


PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome.

Yovich J, Alsbjerg B, Conceicao J, Hinchliffe P, Keane K Drug Des Devel Ther. 2016; 10:2561-73.

PMID: 27563236 PMC: 4986677. DOI: 10.2147/DDDT.S104104.


Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study.

Iliodromiti S, Lan V, Tuong H, Tuan P, Humaidan P, Nelson S J Ovarian Res. 2013; 6(1):93.

PMID: 24369069 PMC: 3877949. DOI: 10.1186/1757-2215-6-93.


The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET.

Jung H, Roh H J Assist Reprod Genet. 2000; 17(1):28-33.

PMID: 10754780 PMC: 3455191. DOI: 10.1023/a:1009445913156.